Bortezomib is an anti-cancer drug used to treat multiple myeloma and mantle cell lymphoma. (3) It is administered in an intravenous mode to treat cancer. It is listed as an Essential Medicine by World Health Organisation.  Originally manufactured in 1995, Bortezomib was clinically tested for its efficiency in treating multiple myeloma. In 2008, it gained...Continue Reading